Raymond James & Associates »

Iovance Biotherapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $997k 67k 14.82
2023-12-31 $138k 17k 8.13
2023-09-30 $59k 13k 4.55
2023-06-30 $91k 13k 7.04
2023-03-31 $62k 10k 6.11
2022-09-30 $190k 20k 9.57
2022-06-30 $219k 20k 11.05
2022-03-31 $256k 15k 16.64
2021-12-31 $192k 10k 19.13
2021-09-30 $203k 8.2k 24.64
2021-06-30 $441k 17k 25.99
2021-03-31 $616k 19k 31.68
2020-12-31 $988k 21k 46.39
2020-09-30 $1.6M 47k 32.92
2020-06-30 $1.1M 41k 27.44
2020-03-31 $1.7M 57k 29.94
2019-12-31 $374k 14k 27.65
2019-09-30 $264k 15k 18.19
2019-06-30 $461k 19k 24.53
2018-06-30 $677k 53k 12.81
2018-03-31 $878k 52k 16.89